Michitaka Imai

2.9k total citations
34 papers, 399 citations indexed

About

Michitaka Imai is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Michitaka Imai has authored 34 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 14 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Michitaka Imai's work include Liver Disease Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Liver Disease and Transplantation (6 papers). Michitaka Imai is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers) and Liver Disease and Transplantation (6 papers). Michitaka Imai collaborates with scholars based in Japan and United States. Michitaka Imai's co-authors include Toru Ishikawa, Toshiaki Yoshida, Terasu Honma, Keiichi Seki, Hidenori Toyoda, Yoichi Hiasa, Yohei Koizumi, Kunihiko Tsuji, Masashi Hirooka and Hironori Ochi and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Medicine.

In The Last Decade

Michitaka Imai

32 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michitaka Imai Japan 12 216 148 101 71 57 34 399
Myung Han Hyun South Korea 9 168 0.8× 135 0.9× 79 0.8× 52 0.7× 43 0.8× 24 373
Nicholas G. Berger United States 12 161 0.7× 128 0.9× 195 1.9× 96 1.4× 187 3.3× 23 427
Víctor Sapena Spain 12 222 1.0× 228 1.5× 74 0.7× 33 0.5× 75 1.3× 35 422
Shigeo Maruyama Japan 9 182 0.8× 188 1.3× 58 0.6× 25 0.4× 46 0.8× 25 378
Alyson A. Melin United States 8 143 0.7× 81 0.5× 157 1.6× 64 0.9× 86 1.5× 11 390
Noriaki Naeshiro Japan 16 390 1.8× 313 2.1× 177 1.8× 49 0.7× 59 1.0× 25 551
Satheesh Iype United Kingdom 11 93 0.4× 137 0.9× 213 2.1× 80 1.1× 124 2.2× 24 470
Daisuke Miyaki Japan 15 381 1.8× 282 1.9× 137 1.4× 48 0.7× 64 1.1× 24 505
Pompilia Radu Romania 12 195 0.9× 177 1.2× 102 1.0× 98 1.4× 58 1.0× 32 405
Tokuhiro Matsubara Japan 14 140 0.6× 105 0.7× 92 0.9× 92 1.3× 172 3.0× 28 510

Countries citing papers authored by Michitaka Imai

Since Specialization
Citations

This map shows the geographic impact of Michitaka Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michitaka Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michitaka Imai more than expected).

Fields of papers citing papers by Michitaka Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michitaka Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michitaka Imai. The network helps show where Michitaka Imai may publish in the future.

Co-authorship network of co-authors of Michitaka Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Michitaka Imai. A scholar is included among the top collaborators of Michitaka Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michitaka Imai. Michitaka Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Takanori, Yasuto Takeuchi, Kazuyuki Mizuno, et al.. (2024). Diagnostic guide for immune checkpoint inhibitor‐induced liver injury. Hepatology Research. 54(8). 719–726. 5 indexed citations
2.
Ishikawa, Toru, et al.. (2022). Effectiveness of different coils for endovascular coiling for intractable hepatic encephalopathy caused by a portosystemic shunt. Annals of Palliative Medicine. 11(6). 1954–1960. 1 indexed citations
3.
Imai, Michitaka, et al.. (2021). Comparison of the efficacy of self‑expandable metallic stents in colorectal obstructions caused by extracolonic malignancy and colorectal cancer. Molecular and Clinical Oncology. 15(2). 170–170. 1 indexed citations
4.
Ohashi, Kazuki, Toru Ishikawa, Michitaka Imai, et al.. (2019). Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease: a cross-sectional study. European Journal of Gastroenterology & Hepatology. 31(11). 1408–1413. 19 indexed citations
5.
Ishikawa, Toru, Michitaka Imai, Marina Politi Okoshi, et al.. (2019). Cone beam versus conventional computed tomography angiography volume measurement in partial splenic embolization. Medicine. 98(5). e14312–e14312. 5 indexed citations
6.
Imai, Michitaka, Toru Ishikawa, Yuichi Kojima, et al.. (2019). Hemorrhagic Gastric Metastasis from Hepatocellular Carcinoma Successfully Treated Using Coil Embolization of the Left Gastric Artery. Internal Medicine. 58(15). 2179–2183. 6 indexed citations
7.
Sato, Hiroki, Terasu Honma, Michitaka Imai, et al.. (2018). Eosinophilic esophagitis in Japanese patients: A mild and slow-progressing disorder. PLoS ONE. 13(11). e0206621–e0206621. 23 indexed citations
8.
Hiraoka, Atsushi, Takashi Kumada, Masatoshi Kudo, et al.. (2017). Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis. Digestive Diseases. 35(6). 602–610. 100 indexed citations
9.
Ishikawa, Toru, Michitaka Imai, Hiroki Sato, et al.. (2017). Serum Wisteria floribunda Agglutinin Positive Mac-2-Binding Protein and Fib-4 Index on the Clinical Course of Patients with Chronic Hepatitis C Receiving Daclatasvir/Asunaprevir Therapy. 1(1). 3 indexed citations
10.
Imai, Michitaka, Kenya Kamimura, Yoshifumi Takahashi, et al.. (2017). The factors influencing long-term outcomes of stenting for malignant colorectal obstruction in elderly group in community medicine. International Journal of Colorectal Disease. 33(2). 189–197. 7 indexed citations
11.
Ishikawa, Toru, Michitaka Imai, Hiroki Sato, et al.. (2017). Hepatic splenosis mimicking hepatocellular carcinoma in a patient with chronic hepatitis C. 2(2). 1 indexed citations
12.
13.
Ishikawa, Toru, Michitaka Imai, Hiroki Sato, et al.. (2017). Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm. Molecular and Clinical Oncology. 7(1). 61–66. 3 indexed citations
14.
Ishikawa, Toru, Michitaka Imai, Hiroki Sato, et al.. (2016). Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve. Biomedical Reports. 6(1). 99–102. 12 indexed citations
15.
Tsuchiya, Atsunori, Michitaka Imai, Hiroteru Kamimura, et al.. (2012). Increased Susceptibility to Severe Chronic Liver Damage in CXCR4 Conditional Knock-Out Mice. Digestive Diseases and Sciences. 57(11). 2892–2900. 14 indexed citations
16.
Imai, Michitaka, Masaya Higuchi, Hiroki Kawamura, et al.. (2012). Human T cell leukemia virus type 2 (HTLV-2) Tax2 has a dominant activity over HTLV-1 Tax1 to immortalize human CD4+ T cells. Virus Genes. 46(1). 39–46. 14 indexed citations
17.
Kamimura, Hiroteru, Toru Ishikawa, Kazuo Higuchi, et al.. (2011). An autopsy case with renal cell carcinoma that presented with rapid progression of liver metastasis without lung metastasis. Kanzo. 52(9). 607–616. 1 indexed citations
18.
Tsuchiya, Atsunori, Michitaka Imai, Hiroteru Kamimura, et al.. (2009). Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil. World Journal of Gastroenterology. 15(14). 1779–1779. 6 indexed citations
19.
Kunitoh, Hideo, Tetsutaro Tamura, Taro Shibata, et al.. (2009). A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). British Journal of Cancer. 100(3). 464–469. 49 indexed citations
20.
Kaneda, Yoshikazu, et al.. (1985). Association of lung cancer and pulmonary fibrosis pathological study of autopsy cases. 55(2). 198–210. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Myung Han Hyun Breakdown of academic impact, for papers by Nicholas G. Berger Breakdown of academic impact, for papers by Víctor Sapena Breakdown of academic impact, for papers by Shigeo Maruyama Breakdown of academic impact, for papers by Alyson A. Melin Breakdown of academic impact, for papers by Noriaki Naeshiro Breakdown of academic impact, for papers by Satheesh Iype Breakdown of academic impact, for papers by Daisuke Miyaki Breakdown of academic impact, for papers by Pompilia Radu Breakdown of academic impact, for papers by Tokuhiro Matsubara
Rankless by CCL
2026